FDA issues final guidance on obtaining informed consent in drug and device clinical trials
Regulatory NewsJoanne S. EglovitchBiologicsBiotechnologyClinical TrialsComplianceMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development